Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?4.0 RB, SLActive? 6mm, RXD: medical device reports filed with FDA

975 reports name it, 2021–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

975
device reports naming the brand
0% of all MAUDE reports · about 202 a year
305
reports, 12 months to August 2026
271 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

975 medical device reports received by FDA name the brand "BLX ?4.0 RB, SLActive? 6mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2021 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

305 reports arrived in the 12 months to August 2026, up 13% from 271 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (70.4%), loss of osseointegration (23.1%) and fracture (0.5%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02448Sep 2021: 2Oct 2021: 5Nov 2021: 14Dec 2021: 52022Jan 2022: 9Feb 2022: 8Mar 2022: 12Apr 2022: 8May 2022: 15Jun 2022: 6Jul 2022: 4Aug 2022: 5Sep 2022: 17Oct 2022: 6Nov 2022: 5Dec 2022: 82023Jan 2023: 14Feb 2023: 7Mar 2023: 11Apr 2023: 10May 2023: 19Jun 2023: 8Jul 2023: 13Aug 2023: 11Sep 2023: 5Oct 2023: 17Nov 2023: 14Dec 2023: 212024Jan 2024: 8Feb 2024: 12Mar 2024: 14Apr 2024: 11May 2024: 19Jun 2024: 13Jul 2024: 22Aug 2024: 21Sep 2024: 22Oct 2024: 30Nov 2024: 32Dec 2024: 192025Jan 2025: 15Feb 2025: 19Mar 2025: 24Apr 2025: 8May 2025: 0Jun 2025: 48Jul 2025: 37Aug 2025: 17Sep 2025: 19Oct 2025: 35Nov 2025: 23Dec 2025: 282026Jan 2026: 19Feb 2026: 19Mar 2026: 16Apr 2026: 34May 2026: 34Jun 2026: 21Jul 2026: 35Aug 2026: 22

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01372732021: 2620212022: 10320222023: 15020232024: 22320242025: 27320252026: 2002026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%975
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report88.5%863
Voluntary report0%0
User facility report0%0
Distributor report11.5%112
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate68670.4%62.8%
Loss of osseointegration22523.1%22.4%
Fracturea broken bone50.5%1.6%
Separation failure10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis37538.5%
Painpain, site not specified18418.9%
Inflammationinflammation495%
Swelling/ edema444.5%
Hemorrhage/blood loss/bleeding414.2%
Hyperresponsive to stimuli222.3%
Fistula131.3%
Abscessa collection of pus111.1%
Hypersensitivity/allergic reaction111.1%
Numbnessnumbness90.9%
Sinus perforation40.4%
Failure of implant10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?4.0 RB, SLActive? 6mm, RXDProduct code DZEAll MAUDE reports
Reports9753,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer88.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?4.0 RB, SLActive? 6mm, RXD reports

How many FDA reports name BLX ?4.0 RB, SLActive? 6mm, RXD?

975 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 305 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (70.4%), loss of osseointegration (23.1%), fracture (0.5%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (88.5%) and distributor reports (11.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?4.0 RB, SLActive? 6mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.